7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
VELTI PLC OR VELT
7.58%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%

Credit Suisse Sued Over MBS Sale

by Zacks Equity Research

October 05, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Credit Suisse Group ( CS - Snapshot Report ) seems to be in sticky waters with litigation issues arising from the sale of mortgage backed securities (MBS). The U.S. regulator for credit unions has sued its unit, Credit Suisse Securities (USA), for misrepresentation in the underwriting and sale of MBS worth over $715 million to three credit unions -- U.S. Central Federal Credit Union, Western Corporate Federal Credit Union, and Southwest Corporate Federal Credit Union, which collapsed later.

The Allegation

Credit Suisse has been accused by the U.S. regulator for credit unions -- National Credit Union Administration (NCUA) of issuing misleading statements and omitting important details from the offering documents of the MBS in question.

This led to obscurity regarding the risks associated with the MBS when they were sold. The credit unions perceived them to be less risky when in fact, the securities bore substantial risk. Moreover, it has been alleged that Credit Suisse has been ignoring the underwriting guidelines specified in the offering documents.

As a result, when these MBS lost their value for defaults in the underlying assets, the value of investments of the credit unions in these MBS plummeted. Subsequently, the three credit unions collapsed, leading to a crisis in the credit union industry.

Others in the Same Pool

Similar suits have been filed in the past by NCUA against other big shots like JPMorgan Chase & Co. ( JPM - Analyst Report ) , Royal Bank of Scotland Group Plc. ( RBS ) and Goldman Sachs Group Inc. ( GS - Analyst Report ) . Moreover, last year, NCUA reached settlements with Deutsche Bank AG ( DB - Snapshot Report ) and Citigroup Inc. ( C - Analyst Report ) worth over $165 million.

Our Take

We believe that such suits would lead to mounting litigation risks for Credit Suisse, which pose a menace for both the company’s image as well as its financials. If found guilty, it is liable to be fined by the authorities.

Often, the company itself opts for settlements in order to reduce litigation hassles. Such a step on behalf of the company exhausts its financials, which could instead have been invested in growth initiatives. We remain skeptical and wait to see what the future holds.

On the other hand, recoveries by NCUA would result in lowering of losses that arose from the failure of the credit unions.

The shares of Credit Suisse retain a Zacks #3 Rank, which translates into a short-term Hold rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.